iVascular's Oceanus 14 Pro PTA Balloon Catheter Receives CE Mark Approval
December 20, 2017—iVascular recently announced the European CE Mark and release of its Oceanus 14 Pro percutaneous transluminal angioplasty balloon catheter, which is indicated to dilate stenoses in femoral, popliteal, and infrapopliteal arteries and treat obstructive lesions in arteriovenous dialysis fistulas.
According to the company, Oceanus 14 Pro has an exceptional crossing profile with a size range that includes small diameters (1.25 and 1.5 mm) and lengths (10 and 15 mm). Additionally, the device adapts its number and type of radiopaque markers for enhanced visibility, flexibility, and trackability: one tungsten radiopaque marker for the smallest and shortest balloons; two tungsten radiopaque markers for smaller diameters and lengths > 20 mm; and two metallic radiopaque markers for other references.
advertisement
Featured Video
Reach lesions and locations previously thought untreatable
Sponsored by Cardiovascular Systems Inc.
Related Articles
Top 5 Articles From November 2017
Ten Steps
A standardized 10-step approach to the planning and sizing of a fenestrated endovascular aortic aneurysm repair.
By Jessica P. Simons, MD, MPH; and Andres Schanzer, MD
Thoracic Aortic Aneurysms: At What Size Should We Intervene?
Key factors to consider when selecting patients for TAA repair.
By Robert J. Hinchliffe, MD, FRCS; and Paul Hollering
Preoperative Risk Assessment for Optimal TEVAR Outcomes
Evaluating which imaging, risk stratification, and system-specific options to consider before thoracic endovascular aortic repair.
By Tristan R. A. Lane, PhD, BSc, MBBS, MRCS; Sadie Syed, MD, MBBS, FRCA; Richard Gibbs, MD, MBChB, FRCS; and Colin D. Bicknell, MD, FRCS
Classification of Aortic Pathologies
A brief review of thoracic aortic aneurysms and acute aortic syndrome, including classic aortic dissection, intramural hematoma, and penetrating aortic ulcer.
By Sharif H. Ellozy, MD
TEVAR and Reintervention: How to Manage Endoleaks and False Lumen Perfusion
Treatment approaches for thoracic aortic aneurysm and thoracic aortic dissection failures.
By Zachary Kostun, MD; and Manish Mehta, MD, MPH
Top 5 from CIToday's Current Issue
Trends in United States TAVR Practice
An update on where TAVR is going as the technology matures in the United States.
By John C. Messenger, MD
Worldwide Trends in TAVR
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
Current Status and Expectations for Low-Risk TAVI Trials
An expert opinion on how current clinical trials will impact the future of TAVI procedures in low-risk patients.
With Marc Dweck, MD, PhD
Risk Assessment for Transcatheter Aortic Valve Replacement
Understanding STS score, EuroSCORE, and frailty indices.
By Troels Højsgaard Jørgensen, MD; and Lars Søndergaard, MD, DMSc
Trends in European TAVI Practice
Current application of TAVI in Europe.
